BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10953048)

  • 1. Evidence that the proposed novel human "neurokinin-4" receptor is pharmacologically similar to the human neurokinin-3 receptor but is not of human origin.
    Sarau HM; Mooney JL; Schmidt DB; Foley JJ; Buckley PT; Giardina GA; Wang DY; Lee JA; Hay DW
    Mol Pharmacol; 2000 Sep; 58(3):552-9. PubMed ID: 10953048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonpeptide tachykinin receptor antagonists. III. SB 235375, a low central nervous system-penetrant, potent and selective neurokinin-3 receptor antagonist, inhibits citric acid-induced cough and airways hyper-reactivity in guinea pigs.
    Hay DW; Giardina GA; Griswold DE; Underwood DC; Kotzer CJ; Bush B; Potts W; Sandhu P; Lundberg D; Foley JJ; Schmidt DB; Martin LD; Kilian D; Legos JJ; Barone FC; Luttmann MA; Grugni M; Raveglia LF; Sarau HM
    J Pharmacol Exp Ther; 2002 Jan; 300(1):314-23. PubMed ID: 11752131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonpeptide tachykinin receptor antagonists. II. Pharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potent and selective NK-3 receptor antagonist.
    Sarau HM; Griswold DE; Bush B; Potts W; Sandhu P; Lundberg D; Foley JJ; Schmidt DB; Webb EF; Martin LD; Legos JJ; Whitmore RG; Barone FC; Medhurst AD; Luttmann MA; Giardina GA; Hay DW
    J Pharmacol Exp Ther; 2000 Oct; 295(1):373-81. PubMed ID: 10992004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonpeptide tachykinin receptor antagonists: I. Pharmacological and pharmacokinetic characterization of SB 223412, a novel, potent and selective neurokinin-3 receptor antagonist.
    Sarau HM; Griswold DE; Potts W; Foley JJ; Schmidt DB; Webb EF; Martin LD; Brawner ME; Elshourbagy NA; Medhurst AD; Giardina GA; Hay DW
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1303-11. PubMed ID: 9190866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurokinin B- and specific tachykinin NK(3) receptor agonists-induced airway hyperresponsiveness in the guinea-pig.
    Daoui S; Naline E; Lagente V; Emonds-Alt X; Advenier C
    Br J Pharmacol; 2000 May; 130(1):49-56. PubMed ID: 10780997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological profile of the novel mammalian tachykinin, hemokinin 1.
    Bellucci F; Carini F; Catalani C; Cucchi P; Lecci A; Meini S; Patacchini R; Quartara L; Ricci R; Tramontana M; Giuliani S; Maggi CA
    Br J Pharmacol; 2002 Jan; 135(1):266-74. PubMed ID: 11786503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchoconstrictor effect of the tachykinin NK₃-receptor agonists [MePhe⁷]-neurokinin B and senktide in the isolated guinea pig lung.
    Corboz MR; Rivelli MA; Eckel SP
    Exp Lung Res; 2010 Nov; 36(9):509-21. PubMed ID: 20939761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexpression of preprotachykinin A and B transcripts in the bovine corpus luteum and evidence for functional neurokinin receptor activity in luteal endothelial cells and ovarian macrophages.
    Brylla E; Aust G; Geyer M; Uckermann O; Löffler S; Spanel-Borowski K
    Regul Pept; 2005 Feb; 125(1-3):125-33. PubMed ID: 15582723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional expression of a novel human neurokinin-3 receptor homolog that binds [3H]senktide and [125I-MePhe7]neurokinin B, and is responsive to tachykinin peptide agonists.
    Krause JE; Staveteig PT; Mentzer JN; Schmidt SK; Tucker JB; Brodbeck RM; Bu JY; Karpitskiy VV
    Proc Natl Acad Sci U S A; 1997 Jan; 94(1):310-5. PubMed ID: 8990205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory actions of tachykinins in the nucleus of the solitary tract: characterization of receptors using selective agonists and antagonists.
    Mazzone SB; Geraghty DP
    Br J Pharmacol; 2000 Mar; 129(6):1121-31. PubMed ID: 10725260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stepwise modulation of neurokinin-3 and neurokinin-2 receptor affinity and selectivity in quinoline tachykinin receptor antagonists.
    Blaney FE; Raveglia LF; Artico M; Cavagnera S; Dartois C; Farina C; Grugni M; Gagliardi S; Luttmann MA; Martinelli M; Nadler GM; Parini C; Petrillo P; Sarau HM; Scheideler MA; Hay DW; Giardina GA
    J Med Chem; 2001 May; 44(11):1675-89. PubMed ID: 11356103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterization of cloned human NK-2 (neurokinin A) receptor expressed in a baculovirus/Sf-21 insect cell system.
    Aharony D; Little J; Powell S; Hopkins B; Bundell KR; McPheat WL; Gordon RD; Hassall G; Hockney R; Griffin R
    Mol Pharmacol; 1993 Aug; 44(2):356-63. PubMed ID: 8394992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of selective tachykinin-receptor antagonists on tachykinin-induced airway mucus secretion in the rat.
    Wagner U; Fehmann H; Bredenbröker D; Klüber D; Lange A; Wichert P
    Neuropeptides; 1999 Feb; 33(1):55-61. PubMed ID: 10657472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution and pharmacological characterization of primate NK-1 and NK-3 tachykinin receptors in the central nervous system of the rhesus monkey.
    Nagano M; Saitow F; Haneda E; Konishi S; Hayashi M; Suzuki H
    Br J Pharmacol; 2006 Feb; 147(3):316-23. PubMed ID: 16331282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of tachykinin receptors in the uterus of the oestrogen-primed rat.
    Magraner J; Pinto FM; Anselmi E; Hernandez M; Perez-Afonso R; Martín JD; Advenier C; Candenas ML
    Br J Pharmacol; 1998 Jan; 123(2):259-68. PubMed ID: 9489614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 2. Identification of (S)-N-(1-phenylpropyl)-3-hydroxy-2-phenylquinoline-4-carboxamide (SB 223412).
    Giardina GA; Raveglia LF; Grugni M; Sarau HM; Farina C; Medhurst AD; Graziani D; Schmidt DB; Rigolio R; Luttmann M; Cavagnera S; Foley JJ; Vecchietti V; Hay DW
    J Med Chem; 1999 Mar; 42(6):1053-65. PubMed ID: 10090788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexistence of three tachykinin receptors coupled to Ca++ signaling pathways in intestinal muscle cells.
    Hellstrom PM; Murthy KS; Grider JR; Makhlouf GM
    J Pharmacol Exp Ther; 1994 Jul; 270(1):236-43. PubMed ID: 8035320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of NK1 and NK2 tachykinin receptors in guinea-pig and rat bronchopulmonary and vascular systems.
    Floch A; Fardin V; Cavero I
    Br J Pharmacol; 1994 Mar; 111(3):759-68. PubMed ID: 7517328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiological effects of tachykinins and capsaicin on guinea-pig bronchial parasympathetic ganglion neurones.
    Myers AC; Undem BJ
    J Physiol; 1993 Oct; 470():665-79. PubMed ID: 7508508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tachykinin-induced contraction of the guinea-pig isolated oesophageal mucosa is mediated by NK(2) receptors.
    Kerr KP; Thai B; Coupar IM
    Br J Pharmacol; 2000 Dec; 131(7):1461-7. PubMed ID: 11090121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.